These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 28538671)

  • 1. Engineering Exosomes for Cancer Therapy.
    Gilligan KE; Dwyer RM
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer exosomes as next-generation cancer immunotherapy.
    Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
    Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes and cancer: From oncogenic roles to therapeutic applications.
    Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
    IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
    Choi JU; Park IK; Lee YK; Hwang SR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
    Alfonsi R; Grassi L; Signore M; Bonci D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes-Small Players, Big Sound.
    Gulei D; Irimie AI; Cojocneanu-Petric R; Schultze JL; Berindan-Neagoe I
    Bioconjug Chem; 2018 Mar; 29(3):635-648. PubMed ID: 29369619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
    Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
    Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
    Srivastava A; Filant J; Moxley KM; Sood A; McMeekin S; Ramesh R
    Curr Gene Ther; 2015; 15(2):182-92. PubMed ID: 25537774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
    Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
    Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic on-demand engineering of exosomes towards cancer immunotherapy.
    Zhao Z; McGill J; Gamero-Kubota P; He M
    Lab Chip; 2019 May; 19(10):1877-1886. PubMed ID: 31044204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery.
    Vakhshiteh F; Rahmani S; Ostad SN; Madjd Z; Dinarvand R; Atyabi F
    Life Sci; 2021 Feb; 266():118871. PubMed ID: 33309716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement, scaling-up, and downstream analysis of exosome production.
    Jafari D; Malih S; Eini M; Jafari R; Gholipourmalekabadi M; Sadeghizadeh M; Samadikuchaksaraei A
    Crit Rev Biotechnol; 2020 Dec; 40(8):1098-1112. PubMed ID: 32772758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome as a Delivery Vehicle for Cancer Therapy.
    Moon B; Chang S
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes-based cell-free cancer therapy: a novel strategy for targeted therapy.
    Dutta A
    Immunol Med; 2021 Jun; 44(2):116-123. PubMed ID: 32924880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.